Table 1.
In vitro investigations on the polyphenolic potential of medicinal plants on different human viruses evaluated.
| Reference | Plants | Compounds | Virus evaluated |
|---|---|---|---|
| Agrawal et al. (2020) | Allium cepa L. | Quercetin and quercetinglycosides | SARS-CoV-2 |
| Luo et al. (2020) | Fructus forsythia, Radix saposhnikoviae, R. glycyrrhizae, R. astragali, Rhizoma Atractylodis macrocephalae and Lonicerae Japonicae Flos | Polyphenols | SARS-CoV-1 |
| Ulasli et al. (2014) | Anthemis hyalina and Nigella sativa | Polyphenols | SARS-CoV-1 |
| Siddiqui et al. (2020) | Citrus aurantium | Hydroxycinnamic acids and flavanone glycosides | SARS-CoV-1 |
| Quercus infectoria G. | Catechin, caffeine, resveratrol, p-coumaric, p-hydroxybenzoic acid, e-vanillic acid and 3-hydroxytyrosol cinnamic | SARS-CoV-1 | |
| Nolkemper et al. (2006) | Salvia officinalis, Melissa officinalis, Rosmarinus officinalis, Mentha piperita, Thymus vulgaris and Prunella vulgaris | Rosmarinic acid, apigenin rutinoside, luteolin, caffeic acid, hesperidin and eriodictyol | HSV-1 and HSV-2 |
| Song et al. (2005) | Camellia sinensis | Epigallocatechin, epicatechin gallate and epigallocatechin gallate | A (H1N1) and A (H3N2) |
| Choi et al. (2009) | Houttuynia cordata | Quercetin 3-rhamnoside | Influenza A |
| Haidari et al. (2009) | Punica granatum | Punicalagin, ellagic acid, luteolin and caffeic acid | A (H1N1), A (H3N2) and influenza B |
| Sornpet et al. (2017) | Psidium guajava, Andrographis paniculata, Gynostemma pentaphyllum, Curcuma longa and Kaempferia parviflora | Polyphenols | Avian A (H5N1) |
| Miki et al. (2007) | Ginkgo biloba | Ginkgetin | A (H1N1) and A (H3N2) |
| Felipe et al. (2006) | Guazuma ulmifolia Lam. and Stryphnodendron adstringens | Catechin, gallocatechin, epicatechin and epigallocatechin | Poliovirus |
| Zuo et al. (2005) | Saxifraga melanocentra Franch | Polyphenols | HCV |
| Yamai et al. (2003) | Glycine max L. Merrill | Polyphenols | ADV and CV |